Cognito Therapeutics is a venture-backed late clinical stage company translating MIT scientific findings into therapies for brain health, including Alzheimer's disease. The fast-moving, highly motivated team aims to help millions impacted by neurodegenerative conditions using patented brain stimulation technology.